Recent Posts in For Pediatric Providers

Jan 7, 2025 - In For Pediatric Providers Mycoplasma Infections on the Rise

Uzma Hasan, MD Division Director, Pediatric Infectious Diseases Cooperman Barnabas Medical Center Mycoplasma pneumoniae is an atypical fastidious organism typically implicated in causing “walking pneumonia”. Bacteria are spread via respiratory droplet ...

Read More

Jan 7, 2025 - In For Pediatric Providers Rising Antibiotic Resistance, With Few New Antibiotics in Development—What Can Pediatricians Do?

Jayshree Kumta, MD Director, Inpatient Pediatrics, Newark Beth Israel Medical Center Amrita Sunkad, MD Pediatric Resident, Newark Beth Israel Medical Center Antibiotic treatment forms an important cornerstone of treatment for infections. The serendipitous ...

Read More

Jan 7, 2025 - In For Pediatric Providers Emerging Infections

Uzma Hasan, MD Clinical Associate Professor, Rutgers NJ Medical School Division Director, Pediatric Infectious Diseases, Cooperman Barnabas Medical Center Eileen Yaney, MS, CIC Administrative Director, Infection Prevention and Control, Cooperman Barnabas ...

Read More

Jan 7, 2025 - In For Pediatric Providers Streptococcal Pharyngitis: Do’s and Don’ts

Renuka Verma, MD Section Chief Pediatric Infectious Disease, Monmouth Medical Center Group A strep, Streptococcus pyogenes (GAS) causes infections such as strep throat and impetigo. GAS can cause both noninvasive and invasive disease, as well as ...

Read More

Jan 7, 2025 - In For Pediatric Providers RSV Updates

Uzma Hasan, MD Clinical Associate Professor, Rutgers NJ Medical School Division Director, Pediatric Infectious Diseases, Cooperman Barnabas Medical Center Rachel Meyers, PharmD Pediatric Clinical Pharmacist, Cooperman Barnabas Medical Center Jessica Lise, ...

Read More

Jan 7, 2025 - In For Pediatric Providers Pertussis

Renuka Verma, MD Section Chief Pediatric Infectious Disease, Monmouth Medical Center Pertussis or whooping cough, begins with mild upper respiratory tract symptoms and progresses to cough, usually paroxysms of cough (paroxysmal stage), characterized by ...

Read More

Jan 7, 2025 - In For Pediatric Providers Pentavalent Meningococcal Vaccine, Penbraya™

Rachel Meyers, PharmD Pediatric Clinical Pharmacist, Cooperman Barnabas Medical Center In October of 2023, the U.S. Food & Drug Administration (FDA) approved Penbraya™, a pentavalent meningococcal vaccine targeted at five serogroups of Neisseria ...

Read More

Jan 7, 2025 - In For Pediatric Providers Blood Cultures

Masako Mizusawa, MD, PhD, MS Director, Microbiology Center of Excellence, RWJBarnabas Health Clinical Associate Professor, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School Mohamed Ellethy, MPH, MLS (ASCP)cm, BS ...

Read More

Jan 7, 2025 - In For Pediatric Providers Meningococcal Disease

Amisha Malhotra, MD Associate Professor, Department of Pediatrics, Division of Pediatric Infectious Disease, Rutgers-Robert Wood Johnson Medical School Meningococcal disease is a serious illness caused by the bacterium Neisseria meningitidis, which can ...

Read More